Cargando…

Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?

AIMS/HYPOTHESIS: Negative effects on the progression of adenocarcinomas by hyperinsulinaemia and the insulin analogue glargine (A21Gly,B31Arg,B32Arg human insulin) have recently been suggested. Most actions of this insulin analogue have hitherto been explained by direct stimulation of growth potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rensing, K. L., Houttuijn Bloemendaal, F. M., Weijers, E. M., Richel, D. J., Büller, H. R., Koolwijk, P., van der Loos, C. M., Twickler, Th. B., von der Thüsen, J. H.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850513/
https://www.ncbi.nlm.nih.gov/pubmed/20182859
http://dx.doi.org/10.1007/s00125-010-1687-y
_version_ 1782179786727096320
author Rensing, K. L.
Houttuijn Bloemendaal, F. M.
Weijers, E. M.
Richel, D. J.
Büller, H. R.
Koolwijk, P.
van der Loos, C. M.
Twickler, Th. B.
von der Thüsen, J. H.
author_facet Rensing, K. L.
Houttuijn Bloemendaal, F. M.
Weijers, E. M.
Richel, D. J.
Büller, H. R.
Koolwijk, P.
van der Loos, C. M.
Twickler, Th. B.
von der Thüsen, J. H.
author_sort Rensing, K. L.
collection PubMed
description AIMS/HYPOTHESIS: Negative effects on the progression of adenocarcinomas by hyperinsulinaemia and the insulin analogue glargine (A21Gly,B31Arg,B32Arg human insulin) have recently been suggested. Most actions of this insulin analogue have hitherto been explained by direct stimulation of growth potential of neoplastic cells and by its IGF-1 related properties. However, insulin-stimulated angiogenesis could be an additional factor involved in tumour progression and clinical outcomes associated with cancer. METHODS: Five types of human adenocarcinoma (breast, colon, pancreas, lung and kidney) were evaluated for the presence of insulin receptors (IRs) on angiogenic structures. In an in vitro angiogenesis assay, various commercially available insulin compounds were evaluated for their potential to increase capillary-like tube formation of human microvascular endothelial cells (hMVEC). Insulin compounds used were: human insulin, insulin lispro (B28Lys,B29Pro human insulin), insulin glargine and insulin detemir (B29Lys[e-tetradecanoyl],desB30 human insulin). RESULTS: Insulin receptors were found to be strongly expressed on the endothelium of microvessels in all evaluated adenocarcinomas, in addition to variable expression on tumour cells. Low or no detectable expression of IRs was seen on microvessels in extratumoral stroma. Incubation with commercially available insulin compounds increased capillary-like tube formation of hMVEC in vitro. CONCLUSIONS/INTERPRETATION: Our results suggest that all tested insulin compounds may stimulate tumour growth by enhancing local angiogenesis. Future studies need to confirm the association between insulin therapy in type 2 diabetes and tumour progression.
format Text
id pubmed-2850513
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28505132010-04-16 Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis? Rensing, K. L. Houttuijn Bloemendaal, F. M. Weijers, E. M. Richel, D. J. Büller, H. R. Koolwijk, P. van der Loos, C. M. Twickler, Th. B. von der Thüsen, J. H. Diabetologia Short Communication AIMS/HYPOTHESIS: Negative effects on the progression of adenocarcinomas by hyperinsulinaemia and the insulin analogue glargine (A21Gly,B31Arg,B32Arg human insulin) have recently been suggested. Most actions of this insulin analogue have hitherto been explained by direct stimulation of growth potential of neoplastic cells and by its IGF-1 related properties. However, insulin-stimulated angiogenesis could be an additional factor involved in tumour progression and clinical outcomes associated with cancer. METHODS: Five types of human adenocarcinoma (breast, colon, pancreas, lung and kidney) were evaluated for the presence of insulin receptors (IRs) on angiogenic structures. In an in vitro angiogenesis assay, various commercially available insulin compounds were evaluated for their potential to increase capillary-like tube formation of human microvascular endothelial cells (hMVEC). Insulin compounds used were: human insulin, insulin lispro (B28Lys,B29Pro human insulin), insulin glargine and insulin detemir (B29Lys[e-tetradecanoyl],desB30 human insulin). RESULTS: Insulin receptors were found to be strongly expressed on the endothelium of microvessels in all evaluated adenocarcinomas, in addition to variable expression on tumour cells. Low or no detectable expression of IRs was seen on microvessels in extratumoral stroma. Incubation with commercially available insulin compounds increased capillary-like tube formation of hMVEC in vitro. CONCLUSIONS/INTERPRETATION: Our results suggest that all tested insulin compounds may stimulate tumour growth by enhancing local angiogenesis. Future studies need to confirm the association between insulin therapy in type 2 diabetes and tumour progression. Springer-Verlag 2010-02-25 2010 /pmc/articles/PMC2850513/ /pubmed/20182859 http://dx.doi.org/10.1007/s00125-010-1687-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Short Communication
Rensing, K. L.
Houttuijn Bloemendaal, F. M.
Weijers, E. M.
Richel, D. J.
Büller, H. R.
Koolwijk, P.
van der Loos, C. M.
Twickler, Th. B.
von der Thüsen, J. H.
Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title_full Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title_fullStr Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title_full_unstemmed Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title_short Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
title_sort could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850513/
https://www.ncbi.nlm.nih.gov/pubmed/20182859
http://dx.doi.org/10.1007/s00125-010-1687-y
work_keys_str_mv AT rensingkl couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT houttuijnbloemendaalfm couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT weijersem couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT richeldj couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT bullerhr couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT koolwijkp couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT vanderlooscm couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT twicklerthb couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis
AT vonderthusenjh couldrecombinantinsulincompoundscontributetoadenocarcinomaprogressionbystimulatinglocalangiogenesis